The effect of calcium channel blocker verapamil on gentamicin nephrotoxicity in rats

Bosnian Journal of Basic Medical Sciences

Volumn 8, Issue 2, 2008, Pages 170-176

  Stojiljković, Nenad ^a   Veljković, Slavimir ^a   Mihailović, Dragan ^a   Stoiljković, Milan ^a   Radovanović, Dragan ^a   Randelović, Pavle ^a  

^a UNIVERSITY OF NI   (Serbia)

Author keywords

Gentamicin; Morphometry; MTHFR; Nephrotoxicity; Rats; Verapamil

Indexed keywords

ANTIINFECTIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; GENTAMICIN; VERAPAMIL;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; DRUG EFFECT; KIDNEY; MALE; METABOLISM; NECROSIS; NEPHRON; PATHOLOGY; RAT; SILVER STAINING; UREA NITROGEN BLOOD LEVEL; WISTAR RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD UREA NITROGEN; CALCIUM CHANNEL BLOCKERS; GENTAMICINS; KIDNEY; MALE; MODELS, BIOLOGICAL; NECROSIS; NEPHRONS; RATS; RATS, WISTAR; SILVER STAINING; VERAPAMIL;

EID: 55949125433     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2008.2977     Document Type: Article

References (17)

1. Niemczyk S., Ludvvicka A., Groniowski M., Lewandowski Z., Hasse Z., Wadyn K.A. Nephrotoxicity of aminoglycosides. II Preventive studies with oral administration of verapamil. Pol. Arch. Med. Wewn. 1991; 85(1): 12-18.
2. Kopple J.D., Ding H., Letoha A., Ivanyi B., Qing D.P., Dux L., Wang H.Y., Sonkodi S. L-carnitine ameliorates gentamicin-induced renal injury in rats. Nephrol. Dial. Transplant. 2002; 17(l2):2122-2131.
3. Ademuyiwa O., Ngaha E.O., Ubah F.O. Vitamin E and selenium in gentamicin nephrotoxicity. Hum. Exp. Toxicol. 1990; 9: 281-288.
4. Kavutcu A., Canbolat O., Ozturk S., Olcay E., Ulutepe S., Ekinci C., Gokhun I.H., Durak I. Reduced enzymatic antioxidant defence mechanism in kidney tissuses from gentamicin treated guinea pigs: Effects of vitamin E and C. Nephron 1996; 72:269-274.
5. Ramsammy L.S., Josepovitz C., Ling K.Y., Lane B., Kaloyanides G.J. Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat. Biochem. Pharmacol. 1987; 36:2125-2132.
6. Watson A.J., Gimenez L.F., Klassen D.K., Stout R.L., Whelton A. Calcium channel blockade in experimental aminoglycoside nephrotoxicity. J. Clin. Pharmacol. 1987; 27(8):625-627.
7. Sokol P.P., Huiatt K.R., Holahan P.D., Ross C.R. Gentamicin and verapamil compete for a common transport in renal brush border membrane vesicles. J. Pharmacol. Exp. Ther. 1990; 251(3): 937-942.
8. Alvarez A., Martul E., Veiga F., Forteza J. Functional, histologic, and ultrastructural study of the protective effects of verapamil in experimental ischemic acute renal failure in the rabbit. Ren. Fail. 1994; 16(2):193-207.
9. Goldfarb D., Lana A., Serbon I., Govenda S., Kapuler S., Eliahon H.E. Beneficial effect of verapamil in ishemic acute renal failure in the rat. Proc. Soc. Exp. Biol. Med. 1983; 172:389-392.
10. Bancroft J.D., Stevens A. Theory and Practice of Histological Techniques, Churchill Livingstone, Nottingham, 1996.
11. Tulkens P. M., M. P. Mingeot-Leclercq, G. Laurent, and R. Bras-seur. Conformational and biochemical analysis of the interactions between phospholipids and aminoglycoside antibiotics in relation with their toxicity, p. 63-93. In: Molecular description of biological membrane components by computer-aided conformational analysis (Brasseur R., ed.),. CRC Press Inc Boca Raton Fla 1990.
12. Gilbert N. Aminoglycosides. In: Principles and Practice of Infectious Disease, 5th ed. (Mandell GL, Bennett JE, Dolin R, eds.), Churchill Livingstone, New York, 2000; 307-336.
13. Mingeot-Leclercq M.P.,Tulkens P.M. Aminoglycosides: nephrotoxicity. Antimicrob. Agents. Chemother.1999; 43:1003-1012.
14. Matsuda O., Beck F.X., Dorge A., Thurau K. Electrolyte composition of renal tubular cells in gentamicin nephrotoxicity. Kidney Int. 1988; 33:1107-1112.
15. Fent K., Mayer E., Zbinden G. Nephrotoxicity screening in rats: a validation study. Arch. Toxicol. 1989; 61:349-358. (Pubitemid 18125883)
16. Matsumura Y., Nishiura M., Deguchi S., Hashimoto N., Ogawa T., Seo R. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats. J. Pharmacol. Exp. Therap.1998; 287:1084-1091.
17. Lopez-Novoa J.M. Potentional role of platelet activating factor in acute renal failure. Kidney Int. 1999; 55:1672-1682.